Literature DB >> 16824934

Influence of skin color on the diagnostic utility of clinical acanthosis nigricans to predict insulin resistance in obese patients.

Juan Carlos Lopez-Alvarenga1, Linda García-Hidalgo, María Victoria Landa-Anell, Rosario Santos-Gómez, Jorge González-Barranco, Anthony Comuzzie.   

Abstract

BACKGROUND: Skin color may influence the presence of acanthosis nigricans (AN) as predictor of insulin resistance (IR). The objective of this study was to determine how skin color influences the diagnostic utility of AN as a marker of IR.
METHODS: We designed a cross-sectional study. Subjects were classified according to their skin color (phototypes I-VI of Fitzpatrick), presence, and severity of AN (Burke quantitative scale). Blood samples were taken for measurement of glucose and insulin to calculate the Matsuda insulin sensitivity index (ISI).
RESULTS: Sixty two obese subjects with BMI of 39.6 +/- 8 were included. Males were more prone to AN (9/12, 75% vs. 24/50, 48%, p <0.085) than females. The neck was the most frequent affected body region (53/62, 85.5%), followed by the elbows (15/62, 24.2%), knuckles (6/62, 9.7%), and knees (4/62, 6.5%). No concordance was found among them. AN was more frequent in those with skin phototype IV (18/23, 78.3%, p = 0.001) than those with phototype III (12/23, 52.2%) and phototype II (3/16, 18.8%). The utility of AN on the neck to predict ISI <3.5 (surrogate of insulin resistance) was sensitivity, 66.7 (95% CI 40.9-79.5); specificity, 82.5 (95% CI 56-95); positive predictive value, 91%; negative predictive value, 48% (p <0.001 for all values).
CONCLUSIONS: People with skin phototype IV have a high frequency of AN on the neck, compared with those with phototypes II and III. Those with AN and skin phototype II showed high specificity and positive predictive values for insulin resistance. Thus, AN is a good marker for IR only in lower phototypes.

Entities:  

Mesh:

Year:  2006        PMID: 16824934     DOI: 10.1016/j.arcmed.2005.12.007

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  6 in total

1.  Prevalence of gestational diabetes mellitus & associated risk factors at a tertiary care hospital in Haryana.

Authors:  Rajesh Rajput; Yogesh Yadav; Smiti Nanda; Meena Rajput
Journal:  Indian J Med Res       Date:  2013-04       Impact factor: 2.375

Review 2.  Acanthosis nigricans in obese adolescents: prevalence, impact, and management challenges.

Authors:  Hak Yung Ng
Journal:  Adolesc Health Med Ther       Date:  2016-12-16

3.  Severe Quantitative Scale of Acanthosis Nigricans in Neck is Associated with Abdominal Obesity, HOMA-IR, and Hyperlipidemia in Obese Children from Mexico City: A Cross-Sectional Study.

Authors:  Ana I Burguete-García; Alan Gilberto Ramírez Valverde; Meztli Espinoza-León; Isaac Sánchez Vázquez; Evelyn Yazmín Estrada Ramírez; Itzel Maldonado-López; Alfredo Lagunas Martínez; Cinthya Estefhany Diaz Benítez; Roberto Karam Araujo; Diana Fernández-Madinaveitia; Adriana E Anides Fonseca; Miguel Cruz; José de Jesús Peralta Romero
Journal:  Dermatol Res Pract       Date:  2022-03-28

4.  Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity.

Authors:  Margoth Caceres; C G Teran; Susana Rodriguez; Marcos Medina
Journal:  BMC Pediatr       Date:  2008-08-12       Impact factor: 2.125

5.  Acanthosis nigricans in the knuckles: An early, accessible, straightforward, and sensitive clinical tool to predict insulin resistance.

Authors:  Gloria González-Saldivar; René Rodríguez-Gutiérrez; Andrés Marcelo Treviño-Alvarez; Minerva Gómez-Flores; Juan Montes-Villarreal; Neri Alejandro Álvarez-Villalobos; Anasofía Elizondo-Plazas; Alejandro Salcido-Montenegro; Jorge Ocampo-Candiani; José Gerardo González-González
Journal:  Dermatoendocrinol       Date:  2018-05-21

6.  Acanthosis nigricans as a composite marker of cardiometabolic risk and its complex association with obesity and insulin resistance in Mexican American children.

Authors:  Juan C Lopez-Alvarenga; Geetha Chittoor; Solomon F D Paul; Sobha Puppala; Vidya S Farook; Sharon P Fowler; Roy G Resendez; Joselin Hernandez-Ruiz; Alvaro Diaz-Badillo; David Salazar; Doreen D Garza; Donna M Lehman; Srinivas Mummidi; Rector Arya; Christopher P Jenkinson; Jane L Lynch; Ralph A DeFronzo; John Blangero; Daniel E Hale; Ravindranath Duggirala
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.